MKS Inc.MKSINASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank57
3Y CAGR-20.4%
5Y CAGR+13.8%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

3Y CAGR
-20.4%/yr
vs +71.2%/yr prior
5Y CAGR
+13.8%/yr
Recent deceleration
Acceleration
-91.6pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive growthRecovering
PeriodValue
202510.33%
2024-5.90%
202319.50%
202220.50%
202115.61%
20205.42%
201920.91%
20182.39%
201719.87%
201661.89%